Biovitrum AB Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Stockholm Sweden (2001)
Status: Acquired by Swedish Orphan Biovitrum (2010) → now Advent International (2021)

Organization Overview

First Clinical Trial
2005
NCT00361348
First Marketed Drug
2001
anakinra (kineret)
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BIOVITRUM AB | Biovitrum AB (publ)